Authors: Schenkel, EJ Skoner, DP Bronsky, EA Miller, SD Pearlman, DS Rooklin, A Rosen, JP Ruff, ME Vandewalker, ML Wanderer, A Damaraju, CV Nolop, KB Mesarina-Wicki, B

Citation: Ej. Schenkel et al., Absence of growth retardation in children with perennial allergic rhinitisafter one year of treatment with mometasone furoate aqueous nasal spray, PEDIATRICS, 105(2), 2000, pp. E221-E227

Authors: Bernstein, DI Berkowitz, RB Chervinsky, P Dvorin, DJ Finn, A Gross, GN Karetzky, M Kemp, JP Laforce, C Lumry, W Mendelson, LM Nelson, H Pearlman, D Rachelefsky, G Ratner, P Repsher, L Segal, AT Selner, JC Settipane, GA Wanderer, A Cuss, FM Nolop, KB Harrison, JE

Citation: Di. Bernstein et al., Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler, RESP MED, 93(9), 1999, pp. 603-612

Authors: Rosenthal, R Berger, W Bronsky, E Dockhorn, R Korenblat, P Lampl, K Lumry, W Pollard, S Raphael, G Rohr, C Shapiro, G Valentine, M Wanderer, A Fleming, L LaVallee, N Stepanians, M Karafilidis, J Shilstone, J Ellis, E

Citation: R. Rosenthal et al., Tri-nasal triamcinolone acetonide nasal spray 200 and 400 mu g qd versus placebo and nasacort triamcinolone acetonide nasal aerosol 440 mu g qd in patients suffering from seasonal allergic rhinitis during the grass season, AM J RHINOL, 12(6), 1998, pp. 427-433